Date: Friday, 5th September 2025
Time: 8:30am – 5:00pm
Location: Sheraton Melbourne Hotel, Melbourne
DEBRA Australia is proud to be hosting this highly-anticipated event for EB health professionals and researchers which will feature speakers from across the globe, including Keynote Speaker Professor Cristina Has from Freiburg University. Guest speakers will showcase the latest updates in clinical care and research in Epidermolysis Bullosa (EB).
The program will include a clinical update on therapies under development, a panel discussion on multidisciplinary models of care for EB, and presentations on the latest DEBRA International Clinical Practice Guidelines. It will also cover research updates on topics including ocular manifestations, wound healing, infection, occupational therapy, scarring, and stem cell therapies in EB.
Continuing Professional Development: 6.5hrs (certificates will be emailed post the event)
Symposium Accommodation: Accommodation availability and bookings for the Sheraton Melbourne Hotel can be made directly, or online via the following group booking link.
Trade displays from the following brands will also be present to visit during the complimentary tea, coffee, and meal breaks to discuss new and updated products relevant to EB care:
- Sutherland Medical
- Wounds Australia
- Base Medical
- Lohmann & Rauscher
- Molnlycke Healthcare
- Smith & Nephew
- Twi Biotechnology Inc.
- Urgo
Keynote Speaker:
- Professor Cristina Has, Head of the Genodermatosis Clinic, Department of Dermatology (Freiburg University, Germany)
With over 20 years of clinical experience in general and paediatric dermatology, specialising in genodermatosis, Professor Cristina Has is an internationally recognised leader in Epidermolysis Bullosa (EB).
Globally renowned for research into the genetic and molecular basis of skin fragility disorders, Professor Cristina Has has advanced understanding of EB subtypes, impact, and therapies. Professor Has is also a member of the Scientific Advisory Board of DEBRA International, and has served as the first author on the latest consensus reclassification of inherited EB and DEBRA International’s Clinical Practice Guidelines.
Guests Speakers include:
- A/Professor Anna Martinez (Great Ormond Street Hospital, London)
- Professor Dimitra Kiritsi (Freiburg University, Germany)
- A/Professor Ulrich Koller (EB House Austria)
- Dr Armen Karamanian (Eliksa Therapeutics)
- Dr Zlatko Kopecki (University of South Australia)
- Dr Chris Turner (University of South Australia)
- Dr Nicholas Veldhuis (Monash University, Australia)
- A/Professor Albert Mellick (Ingham Institute Sydney)
- Ms Erin Georgiou and Ms Tamara Beecroft (The Royal Children’s Hospital Melbourne)
